More on the continuing controversy concerning Aducanumab from Biogen. The FDA has a huge responsibility to ensure that the decision they make on this drug must be in the best interests of "the people", not the drug companies. I think this article offers compelling arguments for not releasing it at this time.
FC
https://www.nytimes.com/2021/05/28/opin ... numab.html
"People Want an Alzheimer's Drug. This Isn't the One" NYTIMES
-
Fc1345linville
- Contributor
- Posts: 151
- Joined: Tue Feb 24, 2015 1:49 pm
- Location: Washington DC area
